19-3595698-CCGGAGCG-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001060.6(TBXA2R):c.1015_1021del(p.Arg339GlyfsTer29) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
TBXA2R
NM_001060.6 frameshift
NM_001060.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.469
Genes affected
TBXA2R (HGNC:11608): (thromboxane A2 receptor) This gene encodes a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. A mutation in this gene results in a bleeding disorder. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBXA2R | NM_001060.6 | c.1015_1021del | p.Arg339GlyfsTer29 | frameshift_variant | 3/3 | ENST00000375190.10 | NP_001051.1 | |
TBXA2R | XM_011528214.3 | c.1015_1021del | p.Arg339GlyfsTer29 | frameshift_variant | 4/4 | XP_011526516.1 | ||
TBXA2R | NM_201636.3 | c.983+32_983+38del | intron_variant | NP_963998.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBXA2R | ENST00000375190.10 | c.1015_1021del | p.Arg339GlyfsTer29 | frameshift_variant | 3/3 | 1 | NM_001060.6 | ENSP00000364336 | P1 | |
TBXA2R | ENST00000589966.1 | c.626_632del | p.Ala209GlyfsTer4 | frameshift_variant | 2/2 | 1 | ENSP00000468145 | |||
TBXA2R | ENST00000411851.3 | c.983+32_983+38del | intron_variant | 2 | ENSP00000393333 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with TBXA2R-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the TBXA2R gene (p.Arg339Glyfs*29). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 5 amino acid(s) of the TBXA2R protein and extend the protein by 23 additional amino acid residues. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.